Institutional Ownership Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX). We have compiled data on the 724 institutions that hold shares in the stock, with a total of 102 Million shares, which have been reported (via 13F filing form) to have a value of $14.7 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
First Trust Advisors LP
Wheaton, IL |
Nov 12, 2025 Q3 2025 |
363,113
shares
|
$52.6 Million
0.04% of portfolio
|
Q3 2025
Reduced 14.25%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
353,640
shares
|
$51.2 Million
1.69% of portfolio
|
Q3 2025
Reduced 19.36%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
347,565
shares
|
$50.3 Million
0.08% of portfolio
|
Q3 2025
New holding
|
|
|
Clearbridge Investments, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
336,936
shares
|
$48.8 Million
0.04% of portfolio
|
Q3 2025
Reduced 1.57%
|
|
|
Axa Investment Managers S.A.
Puteaux, I0 |
Nov 14, 2025 Q3 2025 |
323,896
shares
|
$46.9 Million
0.13% of portfolio
|
Q3 2025
New holding
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
323,611
shares
|
$46.9 Million
0.01% of portfolio
|
Q3 2025
Added 11.88%
|
|
|
Macquarie Group LTD
Australia, C3 |
Nov 13, 2025 Q3 2025 |
315,462
shares
|
$45.7 Million
0.05% of portfolio
|
Q3 2025
Added 16.62%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
303,978
shares
|
$44 Million
0.0% of portfolio
|
Q3 2025
Added 12.01%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 06, 2025 Q3 2025 |
303,510
shares
|
$44 Million
0.04% of portfolio
|
Q3 2025
Reduced 1.84%
|
|
|
Sarissa Capital Management LP
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
303,151
shares
|
$43.9 Million
26.8% of portfolio
|
Q2 2025
Reduced 1.93%
|
|
|
Sei Investments CO
Oaks, PA |
Nov 13, 2025 Q3 2025 |
300,195
shares
|
$43.5 Million
0.05% of portfolio
|
Q3 2025
Added 35.98%
|
|
|
Candriam S.C.A.
|
Nov 05, 2025 Q3 2025 |
287,645
shares
|
$41.7 Million
0.22% of portfolio
|
Q3 2025
Reduced 3.65%
|
|
|
Swiss National Bank
Zurich, V8 |
Nov 13, 2025 Q3 2025 |
285,300
shares
|
$41.3 Million
0.02% of portfolio
|
Q3 2025
Reduced 0.07%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 13, 2025 Q3 2025 |
281,113
shares
|
$40.7 Million
0.14% of portfolio
|
Q3 2025
Added 13.06%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
267,980
shares
|
$38.8 Million
0.01% of portfolio
|
Q4 2024
Reduced 22.45%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2025 Q3 2025 |
258,346
shares
|
$37.4 Million
0.01% of portfolio
|
Q3 2025
Reduced 9.14%
|
|
|
Renaissance Group LLC
Covington, KY |
Nov 05, 2025 Q3 2025 |
251,628
shares
|
$36.5 Million
1.38% of portfolio
|
Q3 2025
Reduced 0.04%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
244,966
shares
|
$35.5 Million
0.01% of portfolio
|
Q3 2025
Added 7.04%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
244,676
shares
|
$35.4 Million
0.01% of portfolio
|
Q2 2025
Added 46.3%
|
|
|
Citigroup Inc
|
Nov 10, 2025 Q3 2025 |
237,082
shares
|
$34.3 Million
0.02% of portfolio
|
Q3 2025
Reduced 26.39%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Nov 04, 2025 Q3 2025 |
231,763
shares
|
$33.6 Million
0.02% of portfolio
|
Q3 2025
Reduced 4.91%
|
|
|
Amundi
Paris, I0 |
Nov 14, 2025 Q3 2025 |
230,263
shares
|
$33.4 Million
0.01% of portfolio
|
Q3 2025
Added 5.05%
|
|
|
Sumitomo Mitsui Trust Holdings, Inc.
|
Oct 27, 2025 Q3 2025 |
221,290
shares
|
$32.1 Million
0.02% of portfolio
|
Q3 2025
Reduced 6.03%
|
|
|
Scout Investments, Inc.
|
Nov 12, 2024 Q3 2024 |
203,501
shares
|
$29.5 Million
0.69% of portfolio
|
Q3 2024
Added 7.18%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
203,407
shares
|
$29.5 Million
0.04% of portfolio
|
Q3 2025
New holding
|
|